Vitrakvi (Larotrectinib)
- Medicine Name: Vitrakvi
- Generic Name: Larotrectinib
- Dosage Form & Strength: Capsules: 25 mg, 100 mg
- Manufactured By: Bayer Pharmaceuticals
Medical Uses
Vitrakvi is designed as a kinase inhibitor for adult and pediatric patients with solid tumors that:
- Have a NTRK gene fusion without any known acquired resistance mutation,
- Are metastatic or where surgical resection can cause serious morbidity, and
- Have no satisfactory alternative therapies or that have progressed after treatment.
Recommended Dosage: The recommended dosage of Vitrakvi capsules for adult and pediatric patients with body surface area (BSA) of minimum 1.0 meter-squared is 100 mg and pediatric patients with BSA not more than 1.0 meter squared is 100 mg/m2 orally twice daily, with or without food, until disease progression or until unacceptable toxicity.
Swallow capsules of Vitrakvi whole with water. It is not advisable to chew or crush the capsules. Avoid making up a missed dose within six hours of the next scheduled dose. If puking occurs just after taking a dose, take the very next dose at the scheduled time.
Warning & Precautions
- Central nervous system (CNS) side effects may occur in patients receiving Larotrectinib, including mood disorders, dizziness, cognitive impairment, and sleep disturbances. Patients should not drive or operate machinery in case of neurologic side effects.
- Quickly assess patients with signs or symptoms of fracture (e.g., changes in mobility, deformity, pain). There are no findings on the effects of Larotrectinib on healing of known fractures or risk of future fractures.
- Those who received Vitrakvi 100 mg, increased AST of any grade may occur and increased ALT of any grade may occur. Assess liver tests, including AST & ALT, every 14 days during the 1st month of therapy, then monthly thereafter.
- On behalf of findings and mechanism of action, Larotrectinib can cause fetal harm if used by a pregnant woman. Women of reproductive age should use a relevant method of contraception during therapy and for 7 days after the last dose of Vitrakvi.
Documentation & Availability
What documents are required to import VITRAKVI to India?
VITRAKVI (larotrectinib) capsules can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is VITRAKVI available in India?
VITRAKVI (larotrectinib capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
VITRAKVI can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of VITRAKVI (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Vitrakvi price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the VITRAKVI (Cancer Treatment Medicines) from across the globe and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Vitrakvi®?
Larotrectinib is a Generic Name for the trade name drug Vitrakvi®.
What is the Manufacturer’s Name of Vitrakvi®?
Vitrakvi® is manufactured by Bayer Pharmaceuticals.
Is Vitrakvi® approved by the FDA?
Yes, Vitrakvi® is approved by the FDA. Date of first/initial approval: November 26, 2018.
Where can I get Vitrakvi® at the best price in India?
To get the best Vitrakvi 100 mg price in India, kindly get in touch with S S Healthcare (a WHO GDP & ISO 9001:2008 certified company). For Vitrakvi®, a valid medical prescription is required from a treating physician.
What is the dosage and form of Vitrakvi® supplied?
Vitrakvi® is supplied as Capsules: 25 mg, 100 mg for oral administration.
Where to Buy Vitrakvi® Injection in India?
Buy Vitrakvi® by Bayer Pharmaceuticals. Get quick delivery of Vitrakvi online from S S Healthcare at the best price. S S Healthcare is a GDP and ISO 9001 2015 certified Pharmaceutical Wholesaler/ Exporter/ Importer, and Vitrakvi supplier in India.
What are the most common side effects of Vitrakvi®?
The most common side effects of Vitrakvi® are constipation, diarrhea, dizziness, low levels of calcium in the blood, vomiting, nausea, fever, stomach pain, cough, tiredness, muscle and bone pain, and low red blood cell (RBC) and white blood cell (WBC) counts.
How much does Vitrakvi® cost in India?
The cost of Vitrakvi in India can vary depending on certain international factors. In order to procure this kinase inhibitor through legal channels, one can Call/WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Vitrakvi®?
Store capsules at temperature 20-25°C (68-77°F); temperature excursions between 15°C and 30°C (59°F to 86°F) are permitted.
Is it safe to buy Vitrakvi® online in India?
Yes, one can buy Vitrakvi capsules at the best price from the S S Healthcare if Vitrakvi is not registered or is unavailable in the respective country. We can facilitate the Import of Vitrakvi through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.